PACS GROUP INC (PACS) Stock Fundamental Analysis

NYSE:PACS • US69380Q1076

40.255 USD
+0.95 (+2.4%)
Last: Feb 26, 2026, 01:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PACS. PACS was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of PACS have multiple concerns. PACS is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • PACS had positive earnings in the past year.
PACS Yearly Net Income VS EBIT VS OCF VS FCFPACS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

  • PACS has a Return On Assets (0.99%) which is comparable to the rest of the industry.
  • PACS has a better Return On Equity (6.40%) than 60.40% of its industry peers.
  • PACS has a Return On Invested Capital (1.75%) which is in line with its industry peers.
  • PACS had an Average Return On Invested Capital over the past 3 years of 4.48%. This is below the industry average of 8.93%.
Industry RankSector Rank
ROA 0.99%
ROE 6.4%
ROIC 1.75%
ROA(3y)3.46%
ROA(5y)N/A
ROE(3y)120.58%
ROE(5y)N/A
ROIC(3y)4.48%
ROIC(5y)N/A
PACS Yearly ROA, ROE, ROICPACS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 50 100 150 200

1.3 Margins

  • PACS has a Profit Margin of 1.36%. This is comparable to the rest of the industry: PACS outperforms 59.41% of its industry peers.
  • PACS's Profit Margin has declined in the last couple of years.
  • PACS has a Operating Margin of 3.01%. This is comparable to the rest of the industry: PACS outperforms 54.46% of its industry peers.
  • PACS's Operating Margin has declined in the last couple of years.
  • PACS has a Gross Margin (19.38%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of PACS has declined.
Industry RankSector Rank
OM 3.01%
PM (TTM) 1.36%
GM 19.38%
OM growth 3Y-25.04%
OM growth 5YN/A
PM growth 3Y-30.78%
PM growth 5YN/A
GM growth 3Y-5.21%
GM growth 5YN/A
PACS Yearly Profit, Operating, Gross MarginsPACS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PACS is destroying value.
  • Compared to 1 year ago, PACS has more shares outstanding
  • PACS has a better debt/assets ratio than last year.
PACS Yearly Shares OutstandingPACS Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M
PACS Yearly Total Debt VS Total AssetsPACS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • PACS has an Altman-Z score of 1.62. This is a bad value and indicates that PACS is not financially healthy and even has some risk of bankruptcy.
  • PACS has a Altman-Z score (1.62) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.43 indicates that PACS is not too dependend on debt financing.
  • PACS has a Debt to Equity ratio of 0.43. This is in the better half of the industry: PACS outperforms 63.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z 1.62
ROIC/WACC0.21
WACC8.28%
PACS Yearly LT Debt VS Equity VS FCFPACS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • PACS has a Current Ratio of 0.94. This is a bad value and indicates that PACS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PACS has a worse Current ratio (0.94) than 73.27% of its industry peers.
  • PACS has a Quick Ratio of 0.94. This is a bad value and indicates that PACS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.94, PACS is not doing good in the industry: 67.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.94
PACS Yearly Current Assets VS Current LiabilitesPACS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The earnings per share for PACS have decreased strongly by -50.86% in the last year.
  • Measured over the past 5 years, PACS shows a small growth in Earnings Per Share. The EPS has been growing by 4.97% on average per year.
  • The Revenue has grown by 31.44% in the past year. This is a very strong growth!
  • The Revenue has been growing by 51.91% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-50.86%
EPS 3Y4.97%
EPS 5YN/A
EPS Q2Q%4500%
Revenue 1Y (TTM)31.44%
Revenue growth 3Y51.91%
Revenue growth 5YN/A
Sales Q2Q%31.01%

3.2 Future

  • PACS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.41% yearly.
  • The Revenue is expected to grow by 10.60% on average over the next years. This is quite good.
EPS Next Y32.6%
EPS Next 2Y34.12%
EPS Next 3Y26.38%
EPS Next 5Y21.41%
Revenue Next Year35.43%
Revenue Next 2Y20.78%
Revenue Next 3Y16.94%
Revenue Next 5Y10.6%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PACS Yearly Revenue VS EstimatesPACS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
PACS Yearly EPS VS EstimatesPACS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 28.15, PACS can be considered very expensive at the moment.
  • PACS's Price/Earnings is on the same level as the industry average.
  • PACS is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.05, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 19.46, which indicates a rather expensive current valuation of PACS.
  • PACS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PACS is cheaper than 64.36% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.03, PACS is valued a bit cheaper.
Industry RankSector Rank
PE 28.15
Fwd PE 19.46
PACS Price Earnings VS Forward Price EarningsPACS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PACS indicates a slightly more expensive valuation: PACS is more expensive than 60.40% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.69
PACS Per share dataPACS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • PACS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • PACS's earnings are expected to grow with 26.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.86
PEG (5Y)N/A
EPS Next 2Y34.12%
EPS Next 3Y26.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for PACS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PACS GROUP INC

NYSE:PACS (2/26/2026, 1:02:09 PM)

40.255

+0.95 (+2.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-19
Earnings (Next)N/A
Inst Owners28.43%
Inst Owner Change4.36%
Ins Owners71.03%
Ins Owner Change0.52%
Market Cap6.30B
Revenue(TTM)4.09B
Net Income(TTM)55.76M
Analysts83.33
Price Target40.63 (0.93%)
Short Float %8.72%
Short Ratio3.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.99%
Min EPS beat(2)8.66%
Max EPS beat(2)13.32%
EPS beat(4)2
Avg EPS beat(4)-6.8%
Min EPS beat(4)-32.29%
Max EPS beat(4)13.32%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.55%
Min Revenue beat(2)13.26%
Max Revenue beat(2)13.85%
Revenue beat(4)4
Avg Revenue beat(4)13.41%
Min Revenue beat(4)13.1%
Max Revenue beat(4)13.85%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)45.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.31%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)15.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)15.81%
Valuation
Industry RankSector Rank
PE 28.15
Fwd PE 19.46
P/S 1.54
P/FCF N/A
P/OCF N/A
P/B 7.24
P/tB 7.85
EV/EBITDA 38.69
EPS(TTM)1.43
EY3.55%
EPS(NY)2.07
Fwd EY5.14%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS26.11
BVpS5.56
TBVpS5.13
PEG (NY)0.86
PEG (5Y)N/A
Graham Number13.38
Profitability
Industry RankSector Rank
ROA 0.99%
ROE 6.4%
ROCE 2.78%
ROIC 1.75%
ROICexc 1.91%
ROICexgc 1.94%
OM 3.01%
PM (TTM) 1.36%
GM 19.38%
FCFM N/A
ROA(3y)3.46%
ROA(5y)N/A
ROE(3y)120.58%
ROE(5y)N/A
ROIC(3y)4.48%
ROIC(5y)N/A
ROICexc(3y)4.61%
ROICexc(5y)N/A
ROICexgc(3y)4.74%
ROICexgc(5y)N/A
ROCE(3y)7.09%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-25.04%
OM growth 5YN/A
PM growth 3Y-30.78%
PM growth 5YN/A
GM growth 3Y-5.21%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA 2.28
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.94
Altman-Z 1.62
F-ScoreN/A
WACC8.28%
ROIC/WACC0.21
Cap/Depr(3y)147.98%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.35%
Cap/Sales(5y)N/A
Profit Quality(3y)200.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.86%
EPS 3Y4.97%
EPS 5YN/A
EPS Q2Q%4500%
EPS Next Y32.6%
EPS Next 2Y34.12%
EPS Next 3Y26.38%
EPS Next 5Y21.41%
Revenue 1Y (TTM)31.44%
Revenue growth 3Y51.91%
Revenue growth 5YN/A
Sales Q2Q%31.01%
Revenue Next Year35.43%
Revenue Next 2Y20.78%
Revenue Next 3Y16.94%
Revenue Next 5Y10.6%
EBIT growth 1Y-40.77%
EBIT growth 3Y13.87%
EBIT growth 5YN/A
EBIT Next Year78.74%
EBIT Next 3Y30.47%
EBIT Next 5Y23.59%
FCF growth 1Y1579.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y476.7%
OCF growth 3Y85.44%
OCF growth 5YN/A

PACS GROUP INC / PACS FAQ

What is the fundamental rating for PACS stock?

ChartMill assigns a fundamental rating of 3 / 10 to PACS.


What is the valuation status of PACS GROUP INC (PACS) stock?

ChartMill assigns a valuation rating of 3 / 10 to PACS GROUP INC (PACS). This can be considered as Overvalued.


What is the profitability of PACS stock?

PACS GROUP INC (PACS) has a profitability rating of 2 / 10.


What is the valuation of PACS GROUP INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PACS GROUP INC (PACS) is 28.15 and the Price/Book (PB) ratio is 7.24.